Skip to main content
S 2742 115th Congress Senate Crime and Law Enforcement Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Food supply, safety, and labeling

SARMs Control Act of 2018

Introduced: April 24, 2018 See on congress.gov
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 24, 2018
Read twice and referred to the Committee on the Judiciary.
Apr 24, 2018
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Selective Androgen Receptor Modulators Control Act of 2018 or the SARMs Control Act of 2018

This bill amends the Controlled Substances Act (CSA) to add SARMs (selective androgen receptor modulators) to schedule III. A SARM is a synthetic drug or substance that has effects similar to testosterone. A schedule III controlled substance (e.g., an anabolic steroid) has less potential for abuse than a schedule I or II substance, has a currently accepted medical use, and has low or moderate risk of dependence if abused.

The bill also:

  • authorizes, and establishes procedures for, the Drug Enforcement Administration (DEA) to temporarily and permanently add a drug or substance to the definition of a SARM;
  • specifies that a felony drug offense includes an offense related to SARMs; and
  • makes it unlawful to import, export, manufacture, distribute, dispense, or possess with intent to manufacture, distribute, or dispense, a SARM that is not clearly labeled.

The bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to notify the DEA when it determines that a new dietary ingredient in a dietary supplement may contain a SARM or SARM analogue.

What's happening now April 24, 2018

Read twice and referred to the Committee on the Judiciary.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2742: SARMs Control Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2742/
MLA
"S. 2742: SARMs Control Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2742/.
Bluebook (legal)
S. 2742, 115th Cong. (2026), https://openamerica.io/bill/115-S-2742/.
Markdown link
[S. 2742: SARMs Control Act of 2018](https://openamerica.io/bill/115-S-2742/)
Report a problem